Compare ROST & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROST | ZTS |
|---|---|---|
| Founded | 1982 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.2B | 54.8B |
| IPO Year | 1994 | 2012 |
| Metric | ROST | ZTS |
|---|---|---|
| Price | $211.43 | $126.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 11 |
| Target Price | ★ $191.81 | $156.20 |
| AVG Volume (30 Days) | 2.0M | ★ 3.9M |
| Earning Date | 06-03-2026 | 05-14-2026 |
| Dividend Yield | 0.82% | ★ 1.68% |
| EPS Growth | ★ 13.67 | 10.05 |
| EPS | 4.61 | ★ 6.02 |
| Revenue | ★ $21,129,219,000.00 | $9,467,000,000.00 |
| Revenue This Year | $8.78 | $5.69 |
| Revenue Next Year | $5.61 | $4.81 |
| P/E Ratio | $42.95 | ★ $21.06 |
| Revenue Growth | ★ 3.69 | 2.28 |
| 52 Week Low | $122.36 | $115.25 |
| 52 Week High | $205.85 | $177.00 |
| Indicator | ROST | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 70.46 | 48.40 |
| Support Level | $177.85 | $118.13 |
| Resistance Level | N/A | $130.08 |
| Average True Range (ATR) | 4.28 | 4.10 |
| MACD | 0.45 | -0.18 |
| Stochastic Oscillator | 77.39 | 54.98 |
Ross Stores, founded in 1982, is a US-focused off-price apparel and home fashion retailer operating more than 2,100 stores across 43 states, primarily under the Ross Dress for Less banner, with a smaller footprint through DD's Discounts. In fiscal 2024, the company generated over $21 billion in sales. Ross offers branded apparel, footwear, accessories, and home goods at a 20%-60% discount to department and specialty store prices, sourcing closeouts and excess inventory from vendors worldwide.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.